诺沃控股公司在印度苏里亚医院购买了49%的股份,价值1.2亿至1.44亿美元,以扩大妇女和儿童的医疗保健。 Novo Holdings bought a 49% stake in India’s Surya Hospitals for $120–144 million to expand women’s and children’s healthcare.

诺沃诺迪斯克基金会的投资部门诺沃控股公司投资了印度最大的妇幼专科医院私营网络苏里亚医院,获得49%的股份。 Novo Holdings, the investment arm of the Novo Nordisk Foundation, has invested in Surya Hospitals, India’s largest private network of women’s and children’s specialty hospitals, acquiring a 49% stake. 这笔价值1,000-1,200卢比的交易支持在孟买、浦那和斋浦尔扩大服务范围,增加获得产科、新生儿和儿科特护、生育和次级专科高质量护理的机会。 The deal, valued at Rs 1,000–1,200 crore, supports expansion in Mumbai, Pune, and Jaipur, enhancing access to high-quality care in obstetrics, neonatal and pediatric intensive care, fertility, and sub-specialties. 投资与新控股公司通过长期、质量驱动的伙伴关系加强印度医疗基础设施的战略相一致。 The investment aligns with Novo Holdings’ strategy to strengthen healthcare infrastructure in India through long-term, quality-driven partnerships. 诺沃的Amit Kakar和Navjeewan Khosla将加入Surya的董事会,而Hulbert Soh将作为观察员。 Amit Kakar and Navjeewan Khosla from Novo will join Surya’s board, while Hulbert Soh will serve as observer. 这笔交易反映出印度保健合并和收购市场在对专门护理和人口变化的需求不断增长的驱动下,势头日益强劲。 The transaction reflects growing momentum in India’s healthcare M&A market, driven by rising demand for specialized care and demographic shifts. 截至2024年,新控股公司管理的资产为1420亿欧元。 As of 2024, Novo Holdings managed EUR 142 billion in assets.